Underpowered or negative? A crucial distinction.: Reply to Dollerup OL, Treebak JT, Jessen N [letter]

Niels J. Connell; Riekelt H. Houtkooper; Patrick Schrauwen

doi:10.1007/s00125-019-4868-3

Underpowered or negative? A crucial distinction. Reply to Dollerup OL, Treebak JT, Jessen N [letter]

Niels J. Connell
, Riekelt H. Houtkooper
, Patrick Schrauwen^*

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

82 Downloads (Pure)

Original language	English
Pages (from-to)	1096-1096
Number of pages	1
Journal	Diabetologia
Volume	62
Issue number	6
DOIs	https://doi.org/10.1007/s00125-019-4868-3
Publication status	Published - Jun 2019

Keywords

Clinical trial
Human
NAD(+) metabolism

Access to Document

10.1007/s00125-019-4868-3

Full TextFinal published version, 107 KBLicence: Taverne

Cite this

@article{fb3f07ec97084db583f20d8f35c790e5,

title = "Underpowered or negative? A crucial distinction.: Reply to Dollerup OL, Treebak JT, Jessen N [letter]",

keywords = "Clinical trial, Human, NAD(+) metabolism",

author = "Connell, \{Niels J.\} and Houtkooper, \{Riekelt H.\} and Patrick Schrauwen",

year = "2019",

month = jun,

doi = "10.1007/s00125-019-4868-3",

language = "English",

volume = "62",

pages = "1096--1096",

journal = "Diabetologia",

issn = "0012-186X",

publisher = "Springer",

number = "6",

}

TY - JOUR

T1 - Underpowered or negative? A crucial distinction.

T2 - Reply to Dollerup OL, Treebak JT, Jessen N [letter]

AU - Connell, Niels J.

AU - Houtkooper, Riekelt H.

AU - Schrauwen, Patrick

PY - 2019/6

Y1 - 2019/6

KW - Clinical trial

KW - Human

KW - NAD(+) metabolism

U2 - 10.1007/s00125-019-4868-3

DO - 10.1007/s00125-019-4868-3

M3 - Comment/Letter to the editor

C2 - 30989254

SN - 0012-186X

VL - 62

SP - 1096

EP - 1096

JO - Diabetologia

JF - Diabetologia

IS - 6

ER -